We leverage our passion, expertise, deep experience and network to help advance new technologies and build market leading companies. Delphi has helped several drugs achieve market approval. Our firm has enabled dozens of companies to expand therapeutic access for patients who need less invasive procedures. Delphi Ventures was founded over 25 years ago as one of the first. Venture capital firms to focus exclusively on investing in life sciences companies. Development-stage biotechnology company dedicated .

We provide catalytic capital to transformative healthcare companies at all stages. Democratizing access to high quality genetic information. Reversing Tumors Associated With Immunosuppression. Revolutionizing Type 2 Diabetes and Obesity Treatment. Protecting People From Food Allergens. Addressing Glaucoma With Triple-Action Eyedrops. Changing the Definition of Sequencing.

Invests in a broad range of healthcare companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs more. Thu, Jan 25th, 2018. Tue, Jan 9th, 2018.

Education Day San Francisco 2018. Education Day San Francisco 2018. Miles for Migraine Community and Education. And 5k and 10k race. To raise money for migraine research. We also host youth camps for kids and teens. Ending Social Stigma and Migraine.

Uncover and profit from exceptional Initial Public Offerings. Find, learn about and invest in IPOs. Interested in investing in IPOs? Our experts have designed investable products that enable investors to access the unique returns of newly public companies before these unseasoned equities are fully represented in core equity portfolios. For more about our IPO investment products, click here.